Veru Provides FDA Update on Request for Emergency Use Authorization for Sabizabulin…
<!-- Name:DistributionId Value:8780823 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
ARDS
BioAegis Therapeutics Announces FDA Clearance of IND for its ‘Inflammation Regulator…
NORTH BRUNSWICK, N.J., Jan. 26, 2023 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, Inc., a clinical-stage company developing therapies for inflammatory diseases through a portfolio built…
Veru Submits Emergency Use Authorization (EUA) Application to U.S. FDA for…
-- The EUA Submission Follows Positive Phase 3 COVID-19 Clinical Trial in which Sabizabulin Demonstrated a 55.2% Reduction in Death in Hospitalized COVID-19 Patients -- -- The Company is…
Beating COVID Is Child’s Play
In this video, Betsy Herold, MD, chief of the Division of Pediatric Infectious Disease at the Children's…
Nirsevimab Prophylaxis Wards Off RSV Infections in Healthy Infants
Healthy infants who received a single prophylactic nirsevimab injection leading up to the…
Dr. Bronner’s Offering Its Workers Psychedelic Therapy Coverage
Dr. Bronner's is touting itself as being among the first U.S. employers to offer…
Heart Failure Patients Still Undertested for CAD
People with new-onset heart failure (HF) continued to lack adequate testing for coronary artery…
Opinion | Cancer Patients Deserve a Chance at a Cure
I can't believe we are back here again.
I know I am not alone in hoping a return to normal…
A Lifeline for First-Generation Nursing Students
A few years ago, Laura Wagner, PhD, was sitting on a graduate admissions committee for the…
Biden Re-Launches His ‘Cancer Moonshot’ Initiative
WASHINGTON -- Doctors need to encourage patients who have missed cancer screenings due to the…